The DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
Anti-Mullerian hormone-based approach to controlled ovarian stimulation for assisted conception
Abstract
BACKGROUND: Individualization of controlled ovarian stimulation (COS) for assisted conception is complicated by variable ovarian response to follicle stimulating hormone. We hypothesized that anti-Müllerian hormone (AMH), a predictor of oocyte yield, may facilitate treatment strategies for women undergoing COS, to optimize safety and clinical pregnancy rates. METHODS: Prospective cohort study of 538 patients in two centres with differential COS strategies based on a centralized AMH measurement. RESULTS: AMH was associated with oocyte yield after ovarian stimulation in both centres, and a 'reduced' AMH (1 to <5 pmol/l) was associated with a reduced clinical pregnancy rate. Women with a 'normal' AMH (5 to <15 pmol/l) treated with a long GnRH-agonist protocol (both centres) showed a low incidence of excess response (0%) and poor response (0%). In women with 'high' AMH (>15 pmol/l), the antagonist protocol eliminated the need for complete cryopreservation of embryos due to excess response (P < 0.001) and showed a higher fresh cycle clinical pregnancy rate than agonist cycles [OR 4.40 (95% CI 1.95-9.93), P < 0.001]. CONCLUSIONS: The use of circulating AMH to individualize treatment strategies for COS may result in reduced clinical risk, optimized treatment burden and maintained pregnancy rates, and is worthy of prospective randomized examination.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Weenen, C. (2004) · Molecular Human Reproduction · doi:10.1093/molehr/gah015 · Cited by 1,285
A systematic review of tests predicting ovarian reserve and IVF outcome
Broekmans, F. J., Kwee, J., Hendriks, D. J., Mol, B. W., & Lambalk, C. B. (2006) · Human Reproduction Update · doi:10.1093/humupd/dml034 · Cited by 1,258
Serum anti-Mullerian hormone levels: a novel measure of ovarian reserve
van Rooij, I. A. J. (2002) · Human Reproduction · doi:10.1093/humrep/17.12.3065 · Cited by 951
The Science behind 25 Years of Ovarian Stimulation for in Vitro Fertilization
Macklon, N. S., Stouffer, R. L., Giudice, L. C., & Fauser, B. C. J. M. (2006) · Endocrine Reviews · doi:10.1210/er.2005-0015 · Cited by 562
Broer, S. L., Mol, B. W. J., Hendriks, D., & Broekmans, F. J. M. (2009) · Fertility and Sterility · doi:10.1016/j.fertnstert.2007.12.013 · Cited by 546
Serum anti-Mullerian hormone throughout the human menstrual cycle
La Marca, A., Stabile, G., Artenisio, A. C., & Volpe, A. (2006) · Human Reproduction · doi:10.1093/humrep/del291 · Cited by 532
Nelson, S. M., Yates, R. W., & Fleming, R. (2007) · Human Reproduction · doi:10.1093/humrep/dem204 · Cited by 391
Self-citationClinical management of low ovarian response to stimulation for IVF: a systematic review
Tarlatzis, B. C. (2003) · Human Reproduction Update · doi:10.1093/humupd/dmg007 · Cited by 365
A mild treatment strategy for in-vitro fertilisation: a randomised non-inferiority trial
Heijnen, E. M., Eijkemans, M. J., De Klerk, C., Polinder, S., Beckers, N. G., Klinkert, E. R., Broekmans, F. J., Passchier, J., Te Velde, E. R., Macklon, N. S., et al. (2007) · The Lancet · doi:10.1016/s0140-6736(07)60360-2 · Cited by 349
GnRH antagonist in assisted reproduction: a Cochrane review
Al-Inany, H. (2002) · Human Reproduction · doi:10.1093/humrep/17.4.874 · Cited by 345
Kolibianakis, E. M., Collins, J., Tarlatzis, B. C., Devroey, P., Diedrich, K., & Griesinger, G. (2006) · Human Reproduction Update · doi:10.1093/humupd/dml038 · Cited by 306
Follicle dynamics during ovarian ageing
Faddy, M. J. (2000) · Molecular and Cellular Endocrinology · doi:10.1016/s0303-7207(99)00238-5 · Cited by 289
Lee, T.-H., Liu, C.-H., Huang, C.-C., Wu, Y.-L., Shih, Y.-T., Ho, H.-N., Yang, Y.-S., & Lee, M.-S. (2007) · Human Reproduction · doi:10.1093/humrep/dem254 · Cited by 279
Nardo, L. G., Gelbaya, T. A., Wilkinson, H., Roberts, S. A., Yates, A., Pemberton, P., & Laing, I. (2009) · Fertility and Sterility · doi:10.1016/j.fertnstert.2008.08.127 · Cited by 266
Streuli, I., Fraisse, T., Pillet, C., Ibecheole, V., Bischof, P., & de Ziegler, D. (2008) · Fertility and Sterility · doi:10.1016/j.fertnstert.2007.06.023 · Cited by 258
Gonadotrophin-releasing hormone antagonists for assisted conception
Al-Inany, H. G., Abou-Setta, A. M., & Aboulghar, M. (2006) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001750.pub2 · Cited by 247
Serum müllerian-inhibiting substance levels during normal menstrual cycles
Cook, C. L., Siow, Y., Taylor, S., & Fallat, M. E. (2000) · Fertility and Sterility · doi:10.1016/s0015-0282(99)00639-1 · Cited by 237
Fauser, B. C. J. M., Diedrich, K., & Devroey, P. (2008) · Human Reproduction Update · doi:10.1093/humupd/dmm034 · Cited by 221
Peñarrubia, J., Fábregues, F., Manau, D., Creus, M., Casals, G., Casamitjana, R., Carmona, F., Vanrell, J. A., & Balasch, J. (2005) · Human Reproduction · doi:10.1093/humrep/deh718 · Cited by 199
Are GnRH antagonists comparable to agonists for use in IVF?
Huirne, J. A. F., Homburg, R., & Lambalk, C. B. (2007) · Human Reproduction · doi:10.1093/humrep/dem270 · Cited by 152
de Klerk, C., Macklon, N., Heijnen, E., Eijkemans, M. J. C., Fauser, B. C. J. M., Passchier, J., & Hunfeld, J. A. M. (2007) · Human Reproduction · doi:10.1093/humrep/dem171 · Cited by 89
Review of the evidence base of strategies to prevent ovarian hyperstimulation syndrome
Mathur, R., Kailasam, C., & Jenkins, J. M. (2007) · Human Fertility · doi:10.1080/14647270601111239 · Cited by 81
Economic evaluations of single- versus double-embryo transfer in IVF
Fiddelers, A. A. A., Severens, J. L., Dirksen, C. D., Dumoulin, J. C. M., Land, J. A., & Evers, J. L. H. (2006) · Human Reproduction Update · doi:10.1093/humupd/dml053 · Cited by 71
Fleming, R., Deshpande, N., Traynor, I., & Yates, R. W. S. (2006) · Human Reproduction · doi:10.1093/humrep/dei499 · Cited by 69
Self-citation
Cited by
The physiology and clinical utility of anti-Müllerian hormone in women
Dewailly, D., Andersen, C. Y., Balen, A., Broekmans, F., Dilaver, N., Fanchin, R., Griesinger, G., Kelsey, T. W., La Marca, A., Lambalk, C., et al. (2014) · Human Reproduction Update · doi:10.1093/humupd/dmt062 · Cited by 1,049
Self-citationAnti-Mullerian hormone (AMH) as a predictive marker in assisted reproductive technology (ART)
La Marca, A., Sighinolfi, G., Radi, D., Argento, C., Baraldi, E., Artenisio, A. C., Stabile, G., & Volpe, A. (2010) · Human Reproduction Update · doi:10.1093/humupd/dmp036 · Cited by 956
Anti-Müllerian hormone: ovarian reserve testing and its potential clinical implications
Broer, S. L., Broekmans, F. J. M., Laven, J. S. E., & Fauser, B. C. J. M. (2014) · Human Reproduction Update · doi:10.1093/humupd/dmu020 · Cited by 683
La Marca, A., & Sunkara, S. K. (2014) · Human Reproduction Update · doi:10.1093/humupd/dmt037 · Cited by 586
Ovarian reserve testing: a user’s guide
Tal, R., & Seifer, D. B. (2017) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2017.02.027 · Cited by 510
Metadata
- Authors
- Nelson, S. M., Yates, R. W., Lyall, H., Jamieson, M., Traynor, I., Gaudoin, M., Mitchell, P., Ambrose, P., & Fleming, R.
- Venue
- Human Reproduction
- Publisher
- Oxford University Press (OUP)
- Published
- 2008-12-26
- Volume
- 24
- Issue
- 4
- Pages
- 867-875
- ISSN
- 0268-1161 (ISSN-L)
- 1460-2350
- OpenAlex
- W2161729104
- Cited by
- 339
- References
- 24
- FWCI
- 23.09
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.